State Street Corp Buys 12,006 Shares of Balchem Co. (NASDAQ:BCPC)

State Street Corp boosted its holdings in Balchem Co. (NASDAQ:BCPC - Free Report) by 1.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,234,226 shares of the basic materials company's stock after buying an additional 12,006 shares during the quarter. State Street Corp owned 3.80% of Balchem worth $217,224,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Conestoga Capital Advisors LLC grew its holdings in shares of Balchem by 1.8% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company's stock worth $206,900,000 after acquiring an additional 20,360 shares during the last quarter. Geneva Capital Management LLC boosted its position in shares of Balchem by 1.7% in the 3rd quarter. Geneva Capital Management LLC now owns 779,869 shares of the basic materials company's stock valued at $137,257,000 after purchasing an additional 12,750 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Balchem by 0.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company's stock valued at $107,372,000 after purchasing an additional 5,977 shares during the period. FMR LLC lifted its stake in Balchem by 944.3% during the third quarter. FMR LLC now owns 497,495 shares of the basic materials company's stock valued at $87,559,000 after buying an additional 449,854 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Balchem by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company's stock worth $63,707,000 after buying an additional 7,562 shares during the period. Institutional investors own 87.91% of the company's stock.

Balchem Stock Down 0.0 %

Shares of NASDAQ:BCPC traded down $0.08 during trading on Thursday, reaching $178.13. 26,040 shares of the company traded hands, compared to its average volume of 109,266. Balchem Co. has a 1-year low of $135.00 and a 1-year high of $186.03. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The firm has a market cap of $5.79 billion, a P/E ratio of 47.91, a price-to-earnings-growth ratio of 5.30 and a beta of 0.67. The firm has a fifty day simple moving average of $174.93 and a 200 day simple moving average of $168.79.

Balchem Increases Dividend

The business also recently disclosed an annual dividend, which will be paid on Friday, January 17th. Investors of record on Thursday, December 26th will be paid a $0.87 dividend. This represents a dividend yield of 0.4%. This is an increase from Balchem's previous annual dividend of $0.79. The ex-dividend date of this dividend is Thursday, December 26th. Balchem's dividend payout ratio (DPR) is presently 23.39%.

Analyst Ratings Changes

Several analysts have issued reports on BCPC shares. HC Wainwright boosted their target price on shares of Balchem from $185.00 to $190.00 and gave the company a "buy" rating in a research note on Monday, November 4th. StockNews.com raised Balchem from a "hold" rating to a "buy" rating in a research note on Monday, October 28th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.